MACQUARIE GROUP LTD - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2021$1,000
-50.0%
1730.0%0.00%
Q2 2021$2,000
-99.7%
173
-99.4%
0.00%
-100.0%
Q1 2021$737,000
-11.7%
30,381
+16.6%
0.00%0.0%
Q4 2020$835,000
+16.8%
26,059
+10.3%
0.00%0.0%
Q3 2020$715,000
+6400.0%
23,626
+9165.1%
0.00%
Q2 2020$11,0002550.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders